Gil Melchor
Director of Investor Relations
Replay available
Trupanion, Inc. (NASDAQ: TRUP) Q1 2026 earnings conference call, held 2026-04-30. Replay captured from the company's public earnings webcast.

Director of Investor Relations
Chief Executive Officer and President
Chief Financial Officer
Analyst, Raymond James
Analyst, Bank of America
Good day and welcome to the Trupanion First Quarter 2026 Earnings Conference Call. All participants will be in listen-only mode. Should you need assistance, please signal a conference specialist by pressing the star key followed by zero. After today's presentation, there will be an opportunity to ask questions. To ask a question, you will press star, then one on a touchtone phone. To withdraw a question, please press star, then two. Please note this event is being recorded. I would now like to turn the conference over to Gil Melchor, Director of Investor Relations. Please go ahead. Good afternoon and welcome to Dupenian's first quarter 2026 Financial Results Conference Call. Participating on today's call are Magi Tu, Chief Executive Officer and President, and Fouad Qureshi, Chief Financial Officer. Before we begin, please be advised that remarks today will contain forward-looking statements. All statements other than statements of historical facts are forward-looking statements. These include, but are not limited to, statements regarding our future operations, key operating metrics, opportunities and financial performance, pricing, and veterinary industry inflation. These statements involve a high degree of known and unknown risks and uncertainties that could cause actual results to differ materially from those discussed. A detailed discussion of these and other risks and uncertainties are included in today's earnings release, as well as the company's most recent reports, including forms 10-K, 10-Q, and 8-K, filed with the Securities and Exchange Commission. Today's presentation contains references to non-GAAP financial measures that management uses to evaluate the company's performance, including without limitation, cost of paying veterinary invoices, variable expen...